Vaccines and otitis media.
Black
S
S
Kaiser Permanente Vaccine Study Center, Oakland, California 94612, USA.
Shinefield
H
H
D000208:Acute Disease; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002648:Child; D005387:Finland; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use; D007251:Influenza, Human / Q000517:prevention & control*; D010033:Otitis Media / Q000382:microbiology / Q000517:prevention & control* / Q000821:virology; D011008:Pneumococcal Infections / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D022261:Respiratory Syncytial Virus Vaccines / Q000627:therapeutic use; D014481:United States; D014765:Viral Vaccines / Q000627:therapeutic use*
D001428:Bacterial Vaccines; D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines; D022261:Respiratory Syncytial Virus Vaccines; D014765:Viral Vaccines